Breast and ovarian cancer predisposition due to de novo BRCA1 and BRCA2 mutations
about
New insights into the generation and role of de novo mutations in health and diseaseA new case of "de novo" BRCA1 mutation in a patient with early-onset breast cancer.Aggregate penetrance of genomic variants for actionable disorders in European and African Americans.The first case report of a large deletion of the BRCA1 gene in Croatia: A case report.Association between Vitamin D receptor (Cdx2, Fok1, Bsm1, Apa1, Bgl1, Taq1, and Poly (A)) gene polymorphism and breast cancer: A systematic review and meta-analysis.
P2860
Breast and ovarian cancer predisposition due to de novo BRCA1 and BRCA2 mutations
description
im Juni 2015 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в червні 2015
@uk
name
Breast and ovarian cancer predisposition due to de novo BRCA1 and BRCA2 mutations
@en
Breast and ovarian cancer predisposition due to de novo BRCA1 and BRCA2 mutations
@nl
type
label
Breast and ovarian cancer predisposition due to de novo BRCA1 and BRCA2 mutations
@en
Breast and ovarian cancer predisposition due to de novo BRCA1 and BRCA2 mutations
@nl
prefLabel
Breast and ovarian cancer predisposition due to de novo BRCA1 and BRCA2 mutations
@en
Breast and ovarian cancer predisposition due to de novo BRCA1 and BRCA2 mutations
@nl
P2093
P2860
P50
P356
P1433
P1476
Breast and ovarian cancer predisposition due to de novo BRCA1 and BRCA2 mutations
@en
P2093
C Barbaroux
C Delnatte
C Houdayer
P2860
P2888
P304
P356
10.1038/ONC.2015.181
P407
P577
2015-06-01T00:00:00Z